Edison, NJ (PRWEB) November 07, 2012
Cryopak, leader temperature controlled package design and manufacturing, recently partnered with Héma-Québec to co-patent a new method for rapidly cooling blood to 22°C for effective collection and storage.
The method (“Rapid cooling to and maintaining of whole blood at 20 to 24C for processing”) was developed using Cryopak's popular phase change product, the Phase 22™ pouch. Upon donation blood is at normal human body temperature and needs to be cooled to room temperature for initial transport and storage. The method involves re-usable pouches filled with Phase 22 that are wrapped around the unit of blood at the time of collection. The Phase 22 removes the heat from the blood equalizing its temperature with the phase change temperature of the PCM.
This is the most effective method on the market to accomplish this task and is now used by Héma-Québec in its blood collection process. This patented method is available in the United States from Cryopak.
About The TCP Family of Companies
The TCP Family of Companies is a complete packaging integrity solutions provider servicing life science industries. The TCP Family consists of Cryopak, a full service solutions provider specializing in the cold chain and DDL, the leader in product, material and package validation testing for the medical device and biopharmaceutical industries. Cryopak consists of three business units dedicated to provide cost effective products and services to our customers. The Cryopak Quality Assurance Group provides expertise in the areas of package design and qualification, temperature profile mapping, and other regulatory compliance services. Cryopak Verification Systems provides temperature monitoring hardware and software platforms to monitor storage facilities and transportation systems. Cryopak Cold Chain Packaging Solutions, specializes in refrigerants and insulated shippers designed for off-the-shelf solutions and custom needs with manufacturing facilities in the US, Canada, and France.